Table 1.
Demographics, Diagnoses, and Type of Treatment Prior to Fertility Preservation of Patients Included in this Study.
| OTC (n=183) | TTC (n=134) | |
|---|---|---|
| Race (%) | ||
| White | 117 (63.9) | 86 (64.2) |
| Other | 26 (14.2) | 30 (22.4) |
| Black | 15 (8.2) | 9 (6.7) |
| Asian | 10 (5.5) | 4 (3.0) |
| Declined to respond | 15 (8.2) | 5 (3.7) |
| Ethnicity (%) | ||
| Hispanic | 29 (15.8) | 30 (22.4) |
| Not Hispanic | 138 (75.4) | 97 (72.4) |
| Declined to respond | 16 (8.7) | 7 (5.2) |
| Diagnosis (%) | ||
| Sarcoma | 64 (35.0) | 30 (22.4) |
| Other solid tumor | 46 (25.1) | 21 (15.7) |
| Leukemia/Lymphoma | 32 (17.5) | 34 (25.4) |
| Benign hematologic condition | 19 (10.4) | 15 (11.2) |
| Brain/Spine tumor | 17 (9.3) | 23 (17.2) |
| Rheumatologic condition | 2 (1.1) | 4 (3.0) |
| Other | 4 (2.2) | 7 (5.2) |
| Treatment Prior to FP (%) | ||
| Radiation therapy | 16 (8.7) | 6 (4.5) |
| Alkylating chemotherapy | 101 (55.2) | 62 (46.3) |